Friday March 12th 2021
No indication of higher risk
Paul Ehrlich Institute is sticking to Astrazeneca
Denmark does not want to inoculate the Astrazeneca vaccine for the time being, Norway and Iceland are also suspending. Some people who had been vaccinated had previously been found to have blood clots. A doctor warns: The vaccination break is likely to do more harm than good. The Paul Ehrlich Institute currently sees no reason to advise against Astrazeneca.
The Paul Ehrlich Institute responsible for vaccines in Germany continues to recommend the corona vaccine from Astrazeneca. So far there has been no evidence that the death in Denmark with the corona vaccination with the Astrazeneca vaccine is “causally connected”, the institute announced in the evening. The European Medicines Agency (EMA) is sticking to the positive evaluation of the approved vaccine from Astrazeneca after an initial review. “In accordance with the EMA, from the point of view of the Paul Ehrlich Institute, the benefit of the vaccination outweighs the known risks,” explained the institute based in Langen.
Denmark had previously suspended vaccinations with the British-Swedish manufacturer’s vaccine. According to the Danish Health Authority, there have been reports of “severe cases” of blood clots in people who have been vaccinated. So far, however, it has not yet been conclusively clarified whether there is a connection between the vaccinations and the coagulation disorders. According to the Danish health authorities, one person died after being vaccinated. As a result, in addition to Denmark, Norway and Iceland also suspended vaccinations with the vaccine, and Romania also wants to pause the use of the batch.
Covid-19 can also cause blood clots
The Paul Ehrlich Institute said that a total of eleven different cases of coagulation disorders with around 1.2 million vaccinations had been reported in Germany by Thursday. Four people died. When looking at all the information currently available on the German and international reports on blood clots after vaccination with the Astrazeneca vaccine, there is “currently no indication that the vaccination caused these diseases”. However, the events that have occurred are being investigated further in close cooperation between the EMA and the European pharmaceutical authorities. After considering the Europe-wide cases, the EMA came to the conclusion that the rate of thrombosis sufferers after vaccination corresponds to the spontaneous occurrence of this disease in the normal population.
According to a German medical professional, the Danish authorities’ decision to suspend administration of the Astrazeneca vaccine could do more harm than good. Blood clots are very common in seriously ill Covid-19 patients, said Mathias Pletz, director of the Institute for Infection Medicine and Hospital Hygiene at the University of Jena. By suspending vaccinations in Denmark for two weeks, it is very likely that more people will now contract Covid-19 than without this decision – and about five percent of them will certainly be severe. As a result, more thromboses could occur. “The decision probably causes more harm than it prevents potential vaccination complications, which we currently do not even know whether they are vaccination complications at all,” said Pletz. That was an inadequate risk-benefit assessment.